Anti-Müllerian Hormone (AMH) has become one of the most important biomarkers in reproductive medicine, widely used to evaluate ovarian reserve, diagnose certain reproductive disorders, and guide fertility treatments. Although the hormone was once primarily studied for its role in fetal development, it is now central to understanding female fertility potential and predicting response to assisted reproductive technologies such as IVF. This comprehensive guide explores what AMH is, how it works, its normal ranges, what influences its levels, and why AMH testing has become indispensable in modern fertility care.
What Is AMH?
Anti-Müllerian Hormone is a glycoprotein hormone produced in women by the granulosa cells of small antral follicles—immature follicles that are still in early stages of development. These follicles are less than 6–8 mm in size and are part of the pool of eggs a woman may recruit for ovulation.
Unlike many other reproductive hormones that fluctuate throughout the menstrual cycle, AMH remains relatively stable. This is because the number of small antral follicles does not vary drastically from day to day, making AMH a consistent and reliable marker of ovarian reserve.
AMH in Early Development
During fetal development in males, AMH is responsible for suppressing the development of female reproductive structures. In females, AMH plays no major role during fetal life but becomes important once the ovaries start to mature around puberty.
Why AMH Matters for Female Fertility
AMH is directly linked to the number of eggs a woman has. Every woman is born with a finite number of eggs—usually around 1 to 2 million. By puberty, this number drops to approximately 300,000. Over the course of reproductive life, only about 300–400 eggs will be ovulated; the rest undergo natural degeneration.
AMH correlates with the pool of small follicles that remain in the ovaries. Higher AMH levels generally mean:
-
A larger ovarian reserve
-
A greater number of recruitable eggs
-
A potentially stronger response to fertility treatments
Conversely, low AMH levels indicate that the ovarian reserve is diminishing, which may make conception more difficult.
AMH Levels and Age
Because ovarian reserve naturally declines with age, AMH levels tend to follow the same downward trend. Peak AMH levels are typically seen in women in their early to mid-twenties, followed by a gradual decline around age 30, and a sharper decline after age 35.
A commonly cited age-based AMH breakdown is:
| Age Group | Typical AMH Level (ng/mL) | Interpretation |
|---|---|---|
| Under 25 | 4.1 – 6.8 | Very high reserve |
| 25–30 | 2.9 – 5.8 | High reserve |
| 31–35 | 1.5 – 4.0 | Normal reserve |
| 36–40 | 0.5 – 1.5 | Reduced reserve |
| Over 40 | < 0.5 | Very low reserve |
It is important to note that these ranges are approximate. AMH values can vary significantly among individuals, and an AMH level that is “low” for one woman may still be normal when interpreted in combination with other clinical factors.
What Is a Good AMH Level?
A “good” AMH level depends on context. For example:
-
For natural conception:
AMH above 1 ng/mL is generally considered promising, although pregnancy can occur even with low AMH as long as ovulation continues. -
For IVF:
Clinicians often prefer an AMH level above 1–1.2 ng/mL to predict a good response to ovarian stimulation. -
For diagnosing PCOS:
AMH levels above 3–5 ng/mL may indicate polycystic ovary syndrome, since women with PCOS typically have a larger number of small follicles.
A single AMH measurement cannot fully determine fertility potential. It must be interpreted alongside age, ultrasound findings, menstrual history, and other hormone levels such as FSH and estradiol.
The AMH Test: How It Works
Procedure
The AMH test is a simple blood test. A small blood sample is taken from a vein in the arm and analyzed in a laboratory.
Timing
Unlike other fertility hormones, AMH remains stable throughout the menstrual cycle, so the test can be done on any day. However, some clinics still recommend testing on day 2 or 3 of the cycle to align with other fertility tests.
Preparation
No fasting is required, and contraceptive pill use does not significantly affect AMH results for most women. Hormone therapy, ovarian surgery, or certain medical treatments may lower AMH temporarily or permanently.
Test Results Timeline
Laboratory turnaround is typically around 7–14 days.
Interpreting AMH Test Results
AMH levels are interpreted in the following general ranges:
| AMH Level (ng/mL) | Interpretation |
|---|---|
| > 4 | High |
| 1.5 – 4 | Normal |
| 1 – 1.5 | Slightly low |
| 0.5 – 1 | Low |
| < 0.5 | Very low |
What High AMH Indicates
-
Possible PCOS
-
Higher number of follicles
-
Potential risk of ovarian hyperstimulation during IVF
-
Likely strong response to fertility medications
What Low AMH Indicates
-
Reduced ovarian reserve
-
Lower egg yield during IVF
-
Possible diminished ovarian reserve (DOR)
-
Higher likelihood of cycle cancellation in IVF
Low AMH does not automatically mean infertility. Women with low AMH may still conceive naturally, especially if they are younger, as egg quality remains good despite low quantity.
AMH, PCOS, and Fertility Diagnosis
Polycystic ovary syndrome is one of the most common endocrine disorders in women, and AMH is frequently elevated in affected individuals. Women with PCOS have an abnormally high number of small follicles, which leads to increased AMH production.
AMH levels above 3–5 ng/mL are commonly seen in PCOS, but AMH alone cannot diagnose the condition. Doctors must also assess:
-
Menstrual irregularities
-
Hormonal imbalances
-
Ultrasound findings
-
Symptoms like acne, hirsutism, or weight gain
AMH is valuable for supporting a PCOS diagnosis but not definitive on its own.
Factors That Influence AMH Levels
Several conditions or lifestyle factors can influence AMH levels:
Factors That May Lower AMH
-
Aging
-
Smoking
-
Ovarian surgery
-
Chemotherapy or radiation
-
Autoimmune disorders
-
Chronic illness
-
Obesity
-
Endometriosis
Factors That May Raise AMH
-
PCOS
-
Presence of numerous small follicles
-
Rare ovarian tumors (granulosa cell tumors)
Understanding these influences helps clinicians avoid misinterpreting test results.
AMH and IVF Success
AMH is one of the strongest predictors of how a woman will respond during IVF stimulation. A high AMH level typically means more eggs can be retrieved, which increases the chance of creating healthy embryos.
However:
-
Egg quality declines with age, regardless of AMH.
-
Older women with high AMH may still have a lower chance of pregnancy due to poorer egg quality.
-
Younger women with low AMH may still have good outcomes because their egg quality remains strong.
Women with very low AMH (< 1 ng/mL) may face challenges during IVF, including:
-
Low egg retrieval count
-
Higher likelihood of cycle cancellation
-
Increased risk of abnormal fertilization
-
Reduced embryo development
In such cases, doctors may use specialized protocols such as the Lupron “flare” protocol or may recommend donor eggs if ovarian reserve is extremely low.
What AMH Cannot Tell You
Despite its usefulness, AMH has limitations. It cannot:
-
Predict the exact time of menopause
-
Guarantee natural pregnancy
-
Assess the quality of eggs
-
Diagnose infertility by itself
-
Predict whether an embryo will implant
AMH is a valuable tool but should always be interpreted within a broader clinical context.
Who Should Consider an AMH Test?
AMH testing is recommended for:
-
Women planning to delay pregnancy
-
Women with irregular periods
-
Those with a family history of early menopause
-
Women undergoing IVF or other fertility treatments
-
Individuals with PCOS symptoms
-
Cancer patients preparing for chemotherapy
-
Women who have had ovarian surgery
It is also useful for assessing suitability for egg freezing.
Treatment Options for Low AMH
Women with reduced ovarian reserve have several options:
1. Lifestyle and Supplements
While no treatment can increase egg count, healthy habits may support fertility:
-
Maintaining a healthy weight
-
Avoiding smoking and alcohol
-
Reducing environmental toxins
-
Taking supplements such as CoQ10 (consult doctor)
2. Fertility Medications
Customized ovarian stimulation protocols enhance egg production in women with low AMH.
3. IVF With Assisted Techniques
-
Assisted hatching
-
ICSI
-
Embryo screening (PGT-A)
These may improve the chances of a successful pregnancy.
4. IVF Using Donor Eggs
For women with critically low ovarian reserve, donor eggs offer the highest success rate.
Conclusion
AMH has become an essential hormone in understanding female fertility. It provides valuable insight into ovarian reserve, helps diagnose reproductive disorders like PCOS, and plays a major role in guiding fertility treatments such as IVF. Although AMH cannot predict pregnancy or egg quality, it remains one of the most reliable tools for assessing reproductive potential.
Monitoring AMH levels empowers women and clinicians alike to make informed decisions about family planning, fertility preservation, and treatment strategies. Ultimately, AMH is an important piece of the fertility puzzle—one that helps illuminate a woman’s reproductive future and expand her options along the journey to parenthood.
summary
The article explains the role of Anti-Müllerian Hormone (AMH) as a key indicator of a woman’s ovarian reserve—the number of eggs remaining in the ovaries. AMH is produced by small antral follicles and remains relatively stable throughout the menstrual cycle, making it a reliable fertility marker. Normal AMH levels vary by age, with women under 35 typically falling between 1.5–4 ng/mL. Lower levels suggest diminished ovarian reserve, while higher levels may indicate conditions like PCOS.
The AMH test is a simple blood test used to assess fertility potential, guide IVF medication dosage, diagnose PCOS, and evaluate risks of early menopause. Results can help predict how the ovaries will respond to fertility treatments but cannot determine the exact timing of menopause or guarantee pregnancy success.
Various factors—such as age, chemotherapy, obesity, smoking, and ovarian surgery—may influence AMH levels. Women with low AMH may need fertility treatments such as specialized IVF protocols or donor eggs. Monitoring AMH helps individuals and doctors make informed decisions about family planning and treatment options.